Eli Lilly (LLY) Interest Expenses (2009 - 2012)

Eli Lilly has reported Interest Expenses for 4 years, with the latest figure at $45.3 million in Q1 2012.

• For the quarter ending Q1 2012, Interest Expenses fell 1.09% year-over-year to $45.3 million; the trailing twelve-month figure through Dec 2012 stood at $45.3 million (down 75.65% YoY), and the FY2011 full-year result was $186.0 million, changed 0.27% from the prior year.
• Interest Expenses for Q1 2012 stood at $45.3 million, down from $50.1 million in the prior quarter.
• The five-year high for Interest Expenses was $64.3 million in Q2 2009, with the low at $43.2 million in Q4 2010.
• Historically, Interest Expenses has averaged $48.1 million across 4 years, with a median of $46.5 million in 2010.
• Annual changes were most pronounced in 2010 — Interest Expenses decreased 26.13% — and 2011, when it rose 15.97%.
• Eli Lilly's Interest Expenses stood at $64.3 million in 2009, then plunged by 32.81% to $43.2 million in 2010, then gained by 15.97% to $50.1 million in 2011, then slipped by 9.58% to $45.3 million in 2012.
• The last three Interest Expenses figures came in at $45.3 million (Q1 2012), $50.1 million (Q4 2011), and $45.0 million (Q3 2011), per Business Quant data.